Position in VRTX
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$1,043,133
+$150,053 QoQ
Shares Held
2,100
+5.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#833
of 1,732 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$397,384
PutShares
800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bay Rivers Group holds $2,573,645 across 3 Biotechnology names. VRTX ranks #2 (40.5% of the industry book) .
All Filings in VRTX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,043,133 | 2,100 | Shares | Sole | 2026-07-09 | |
| 2026-06-30 | $397,384 | 800 | Put | Sole | 2026-07-09 | |
| 2026-03-31 | $893,080 | 2,000 | Shares | Sole | 2026-04-13 | |
| No filing history on record for this holder in this stock. | ||||||